Literature DB >> 10469123

PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.

A Besson1, S M Robbins, V W Yong.   

Abstract

The level of phosphorylation within cells is tightly regulated by the concerted action of protein kinases and protein phosphatases [Hunter, T. (1995) Cell 80, 225-236]. Disregulation in the activity of either of these players can lead to cellular transformation. Many protein tyrosine kinases are proto-oncogenes and it has been postulated that some protein phosphatases may act as tumor suppressors. Herein we will review the recent findings addressing the roles the candidate tumor suppressor PTEN/MMAC1/TEP1 (PTEN, phosphatase and tensin homologue deleted from chromosome 10; MMAC 1, mutated in multiple advanced cancers 1; TEP1, TGF beta regulated and epithelial cell enriched phosphatase 1) plays in signal transduction and tumorigenesis. PTEN is a dual specificity protein phosphatase (towards phospho-Ser/Thr and phospho-Tyr) and, unexpectedly, also has a phosphoinositide 3-phosphatase activity. PTEN plays an important role in the modulation of the 1-phosphatidylinositol 3-kinase (PtdIns 3-kinase) pathway, by catalyzing the degradation of the PtdIns(3,4,5)P3 generated by PtdIns 3-kinase; this inhibits the downstream functions mediated by the PtdIns 3-kinase pathway, such as activation of protein kinase B (PKB, also known as Akt), cell survival and cell proliferation. Furthermore, PTEN modulates cell migration and invasion by negatively regulating the signals generated at the focal adhesions, through the direct dephosphorylation and inhibition of focal adhesion kinase (FAK). Growth factor receptor signaling is also negatively regulated by PTEN, through the inhibition of the adaptor protein Shc. While some of the functions of PTEN have been elucidated, it is clear that there is much more to discover about the roles of this unique protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469123     DOI: 10.1046/j.1432-1327.1999.00542.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  24 in total

1.  RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.

Authors:  Megumi Iiizumi; Sucharita Bandyopadhyay; Sudha K Pai; Misako Watabe; Shigeru Hirota; Sadahiro Hosobe; Taisei Tsukada; Kunio Miura; Ken Saito; Eiji Furuta; Wen Liu; Fei Xing; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

2.  SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading.

Authors:  N Prasad; R S Topping; S J Decker
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 3.  Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.

Authors:  A Besson; V W Yong
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

4.  Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation.

Authors:  X Shan; M J Czar; S C Bunnell; P Liu; Y Liu; P L Schwartzberg; R L Wange
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Effects and mechanisms of silibinin on human hepatoma cell lines.

Authors:  John-J Lah; Wei Cui; Ke-Qin Hu
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

6.  Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.

Authors:  Hao Deng; Ren-Liang Wu; Hong-Yan Zhou; Xuan Huang; Ying Chen; Li-Jiang Liu
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

7.  Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products.

Authors:  Hua-Chuan Zheng; Yi-Ling Li; Jin-Min Sun; Xue-Fei Yang; Xiao-Han Li; Wei-Guo Jiang; Yin-Chang Zhang; Yan Xin
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

8.  Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer.

Authors:  Ye-Jiang Zhou; Yu-Xia Xiong; Xiao-Ting Wu; De Shi; Wei Fan; Tong Zhou; Yue-Chun Li; Xiong Huang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.

Authors:  Stanley F Barnett; Deborah Defeo-Jones; Sheng Fu; Paula J Hancock; Kathleen M Haskell; Raymond E Jones; Jason A Kahana; Astrid M Kral; Karen Leander; Ling L Lee; John Malinowski; Elizabeth M McAvoy; Debbie D Nahas; Ronald G Robinson; Hans E Huber
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

10.  Correlation between metastatic potential and variants from colorectal tumor cell line HT-29.

Authors:  Min Wang; Ilka Vogel; Holger Kalthoff
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.